U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Medical Devices
  3. Device Advice: Comprehensive Regulatory Assistance
  4. Contact Us – Division of Industry and Consumer Education (DICE)
  5. REdI Conference
  1. Contact Us – Division of Industry and Consumer Education (DICE)

REdI Conference

The Regulatory Education for Industry (REdI) Program is a free FDA-led conference that brings together the regulatory educators from the FDA's medical product centers: Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH), and Center for Biologics Evaluation and Research (CBER).

Goal:

To educate the regulatory community with current information about FDA’s regulation of drugs, devices, and biologics.

Audience:

Small manufacturers, researchers, and innovators seeking to learn about how the FDA regulates drugs, devices, and biologics medical products.

Program Series and Format:

  • The conference is offered in a hybrid format, with both virtual and in-person presentations.
  • For each FDA medical product center, REdI features a plenary session that combines the themes of drugs (CDER), devices (CDRH), and biologics (CBER) regulatory policy.
  • Topics span total product lifecycle.

REdI 2024

REdI 2024 was held on May 29-30, 2024, with well over 20,000 online and in-person attendees! Recordings of the 13 CDRH sessions are available here:

You may access individual topics by selecting the chapter.

Recent REdI Programs:

Back to Top